4.5 Article

Pre-treatment hematuria and crescents predict estimated glomerular filtration rate trajectory after methylprednisolone pulse therapy with tonsillectomy for IgA nephropathy

期刊

JOURNAL OF NEPHROLOGY
卷 35, 期 2, 页码 441-449

出版社

SPRINGER HEIDELBERG
DOI: 10.1007/s40620-021-01064-4

关键词

IgA nephropathy; Methylprednisolone pulse therapy with tonsillectomy; Severity of pre-treatment hematuria; Cellular; fibrocellular crescent

向作者/读者索取更多资源

This study found that in patients with IgA nephropathy, those with severe pre-treatment hematuria or a high percentage of crescents are likely to see an improvement in eGFR after methylprednisolone pulse therapy with tonsillectomy.
Background Glomerular hematuria and proteinuria are typical manifestations of IgA nephropathy (IgAN). However, hematuria severity is not considered a useful marker of the potential benefits of corticosteroid administration as proteinuria severity only is included in the current guidelines. Methods In this retrospective cohort study, we enrolled 133 patients diagnosed with IgAN through biopsy. We calculated the 2-year estimated glomerular filtration rate (eGFR) slope (mL/min/1.73m(2)/year) and eGFR trajectory after methylprednisolone pulse therapy using mixed effects models stratified by the Oxford classification and three categories of pre-treatment hematuria: mild [urinary red blood cells (URBCs) < 10/high-power field (HPF)], moderate (URBCs 10-30/HPF), and severe (URBCs >= 30/HPF). Results The severe pre-treatment hematuria group showed a significantly higher likelihood of having crescents (odds ratio (OR), 4.3; 95% confidence interval (CI), 1.7-10.9). In the longitudinal analysis of 103 patients, most of whom underwent tonsillectomy, the severe pre-treatment hematuria group had a significantly higher 2-year eGFR slope after methylprednisolone pulse therapy than the mild and moderate hematuria groups (mild, -0.52 +/- 1.97; moderate, -0.32 +/- 1.99; severe, 1.44 +/- 3.20 mL/min/1.73m(2)/year). Patients with C2 scores showed a significantly higher 2-year eGFR slope after methylprednisolone pulse therapy than those with C0 and C1 scores (C0, -0.38 +/- 1.74; C1, 0.81 +/- 3.02; C2, 3.29 +/- 3.68 mL/min/1.73m(2)/year). Analyses of eGFR trajectory after methylprednisolone pulse therapy revealed that the eGFR improved only in patients with severe pre-treatment hematuria or C2 score (P-interaction with time < 0.001). Conclusions The eGFR is likely to improve after methylprednisolone pulse therapy with tonsillectomy in IgAN patients with severe pre-treatment hematuria or a high percentage of crescents.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据